“…5-HT 1A receptor agonists have also neuroprotective effects in animal models including central nervous system ischemia (Saruhashi et al, 2002, Mauler & Horvath, 2005, Ramos et al, 2004, Kukley et al, 2001, Torup et al, 2000, Piera et al, 1995, acute subdermal hematoma (Fournier et al, 1993), traumatic brain injury (Alessandri et al, 1999, Kline et al, 2002, excitotoxicity (Oosterink et al, 2003, Cosi et al, 2005, a Parkinson's disease model animal induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Bibbiani et al, 2001, Bezard et al, 2006, and sciatic nerve crush (Fournier et al, 1993). Additionally, it was reported that the 5-HT 1A agonists delayed the progression of motor neuron degeneration in pmn mice (Duong et al, 1998) and reduced lipid peroxidation in a rat epilepsy model (de Freitas et al, 2010). Such neuroprotective effects are considered to be caused by neuronal membrane hyperpolarization via G protein-coupled K + channels, decreasing glutamate release, blocking Ca 2+ channels or Na + channels, activation of MAPK (mitogen-actiated protein kinase)/ERK (extracellular signal-regulated kinase) signalling pathway resulting expression of anti-apoptotic proteins and inhibition of caspase, and an expression of brain derived neurotrophic factor (BDNF) mRNA, S100β and nerve growth factor.…”